Ken Stern & Associates’s Intel INTC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
$651K Buy
13,756
+5
+0% +$243 0.28% 50
2018
Q2
$684K Sell
13,751
-999
-7% -$53K 0.32% 35
2018
Q1
$768K Sell
14,750
-688
-4% -$32.7K 0.34% 30
2017
Q4
$713K Sell
15,438
-2,042
-12% -$89.1K 0.31% 34
2017
Q3
$670K Buy
17,480
+1,400
+9% +$49.8K 0.3% 35
2017
Q2
$540K Buy
16,080
+13
+0.1% +$465 0.25% 45
2017
Q1
$581K Sell
16,067
-292
-2% -$10.6K 0.27% 37
2016
Q4
$593K Buy
16,359
+2,160
+15% +$77.3K 0.31% 34
2016
Q3
$536K Buy
14,199
+7
+0% +$248 0.37% 34
2016
Q2
$465K Sell
14,192
-14,711
-51% -$461K 0.37% 42
2016
Q1
$935K Buy
28,903
+4,131
+17% +$127K 0.65% 23
2015
Q4
$853K Buy
24,772
+998
+4% +$33.7K 0.57% 31
2015
Q3
$717K Buy
23,774
+3,387
+17% +$97.9K 0.56% 28
2015
Q2
$620K Buy
20,387
+1,393
+7% +$45K 0.45% 32
2015
Q1
$594K Buy
18,994
+4,330
+30% +$146K 0.45% 37
2014
Q4
$532K Buy
+14,664
New +$510K 0.41% 54

Other funds holding INTC

Ken Stern & Associates's INTC Position: Q3 2018 in Review

Ken Stern & Associates increased its Intel (INTC) stake by 0.04% in Q3 2018, buying an estimated $243 and bringing the position to 13,756 shares worth $651K. The position accounts for 0.28% of the portfolio, ranked #50.

Ken Stern & Associates first reported a position in INTC in Q4 2014 and has held it in 16 quarters since. The position peaked at $935K in Q1 2016. 2,213 funds tracked by Wall St. Rank hold INTC as of Q3 2018.

  • Ken Stern & Associates held 13,756 shares of Intel worth $651K as of Q3 2018.
  • Ken Stern & Associates bought 5 Intel shares in Q3 2018, an estimated $243.
  • Intel made up 0.28% of Ken Stern & Associates's portfolio in Q3 2018, its #50 holding.
  • Ken Stern & Associates first reported a position in Intel in Q4 2014 and has held it in 16 quarters since.
  • Ken Stern & Associates's Intel position peaked at $935K in Q1 2016.
  • 2,213 funds tracked by Wall St. Rank held Intel as of Q3 2018.

Based on Ken Stern & Associates's 13F filing for Q3 2018, filed 13 Nov 2018.